Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma.
Castelli R, Taranto S, Furiassi L, Bozza N, Marseglia G, Ferlenghi F, Rivara S, Retini M, Bedini A, Spadoni G, Matarazzo S, Ronca R, Presta M, Mor M, Giacomini A.
Castelli R, et al. Among authors: furiassi l.
Eur J Med Chem. 2021 Oct 5;221:113529. doi: 10.1016/j.ejmech.2021.113529. Epub 2021 May 5.
Eur J Med Chem. 2021.
PMID: 34004471